Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults

OBJECTIVE: To assess the antibody response in non-immunocompromised adults after two doses of BNT162b2. METHODS: Prospective, single-centre observational study in non-immunocompromised adults aged 18 years or more who received two doses of BNT162b2. The study contemplates analyses of serum samples c...

Descripción completa

Detalles Bibliográficos
Autores principales: Erice, Alejo, Varillas-Delgado, David, Caballero, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426320/
https://www.ncbi.nlm.nih.gov/pubmed/34508885
http://dx.doi.org/10.1016/j.cmi.2021.08.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426320/
https://www.ncbi.nlm.nih.gov/pubmed/34508885
http://dx.doi.org/10.1016/j.cmi.2021.08.023

Ejemplares similares